Acadia Healthcare: Q2 Earnings Snapshot
Acadia Healthcare Co. (ACHC) reported Q2 net income of 12 cents per share and adjusted earnings of 38 cents per share, versus a Zacks mean estimate of 33 cents. Revenue was $865.8 million, above the $844.7 million forecast. Full-year guidance calls for EPS of $1.45 to $1.60 and revenue of $3.4 billion to $3.45 billion.
How this was made
The 30-second read
Why it matters
The key new tradable inputs are the reported Q2 EPS and revenue beats versus Zacks expectations and the stated full-year EPS and revenue guidance ranges.
Market read
Traders can update earnings models and near-term expectations using the beat and the explicit full-year guidance ranges.
What to watch
The article does not break out margin drivers, patient volumes, payer mix, or impairment/non-recurring items, which can matter for whether the beat is durable.
Background
Acadia Healthcare is an inpatient behavioral health services provider; this is a Q2 earnings snapshot with consensus comparisons and full-year guidance ranges.
Ticker impact
Acadia Healthcare reported Q2 adjusted EPS of 38 cents vs 33 cents expected, plus revenue of $865.8M vs $844.7M, and issued full-year EPS and revenue guidance.
Likely modest positive follow-through versus peers if investors focus on the beat and the $1.45 to $1.60 EPS guidance range.
The text includes a concrete earnings and revenue beat versus consensus and provides explicit full-year guidance ranges, which are actionable for positioning into subsequent quarters.
Market effects
Behavioral health inpatient operators may see read-across demand for earnings quality and guidance credibility.
Limited; company is US-focused with no regional macro linkage in the text.
Low; no international drivers or cross-border policy/regulatory items mentioned.
Counterpoint
The stock has already more than doubled YTD, so the market may discount the beat if guidance is viewed as merely in-line or not aggressive enough.
Key entities
- companyAcadia Healthcare Co.
Reported Q2 results and provided full-year earnings and revenue guidance ranges.
